Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,645
Closed -$660 390
2019
Q3
$660 Buy
6,645
+23
+0.3% +$2.19K 0.02% 256
2019
Q2
$612 Sell
6,622
-1,232
-16% -$117K 0.02% 253
2019
Q1
$741K Sell
7,854
-3,632
-32% -$318K 0.02% 234
2018
Q4
$736 Buy
11,486
+993
+9% +$73.3K 0.02% 219
2018
Q3
$939K Buy
10,493
+18
+0.2% +$1.59K 0.03% 215
2018
Q2
$832K Sell
10,475
-12,695
-55% -$1.05M 0.03% 221
2018
Q1
$2.07M Sell
23,170
-11,771
-34% -$1.13M 0.07% 165
2017
Q4
$3.65M Sell
34,941
-828
-2% -$93.4K 0.12% 134
2017
Q3
$5.22M Sell
35,769
-287
-0.8% -$39.1K 0.18% 109
2017
Q2
$4.68M Buy
36,056
+6,607
+22% +$810K 0.16% 113
2017
Q1
$3.67M Buy
29,449
+14,467
+97% +$1.73M 0.13% 120
2016
Q4
$1.73M Sell
14,982
-1,580
-10% -$176K 0.06% 168
2016
Q3
$1.73M Sell
16,562
-112
-0.7% -$12.1K 0.07% 168
2016
Q2
$1.64M Sell
16,674
-1,393
-8% -$144K 0.07% 171
2016
Q1
$1.81M Sell
18,067
-2,897
-14% -$298K 0.08% 157
2015
Q4
$2.51M Sell
20,964
-43,430
-67% -$5.02M 0.11% 147
2015
Q3
$6.97M Sell
64,394
-1,023
-2% -$127K 0.41% 64
2015
Q2
$7.57K Sell
65,417
-4,038
-6% -$462K 0.35% 72
2015
Q1
$8.01K Buy
69,455
+1,337
+2% +$160K 0.36% 72
2014
Q4
$7.62M Buy
68,118
+1,710
+3% +$180K 0.34% 74
2014
Q3
$6.29K Buy
66,408
+44,816
+208% +$4.04M 0.31% 78
2014
Q2
$1.85M Sell
21,592
-4,278
-17% -$325K 0.09% 141
2014
Q1
$1.81M Sell
25,870
-2,610
-9% -$207K 0.1% 134
2013
Q4
$2.41K Sell
28,480
-2,234
-7% -$177K 0.13% 116
2013
Q3
$2.37K Sell
30,714
-22,784
-43% -$1.6M 0.14% 116
2013
Q2
$3.13K Buy
+53,498
New +$3.22M 0.18% 102

Other funds holding CELG

UMB Bank's CELG Position: Q4 2019 in Review

UMB Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,645 shares — an estimated $660 sold.

UMB Bank first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.62M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • UMB Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • UMB Bank sold 6,645 Celgene Corp shares in Q4 2019, an estimated $660.
  • UMB Bank first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • UMB Bank's Celgene Corp position peaked at $7.62M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on UMB Bank's 13F filing for Q4 2019, filed 31 Jan 2020.